NF-κB-IN-14
NF-κB-IN-14 (compound 5e) significantly inhibits nitric oxide production in LPS-induced macrophages (IC50: 6.4 μM) . NF-κB-IN-14 disrupts the TLR4-MyD88 protein interaction, leading to the suppression of the NF-κB signaling pathway suppression. NF-κB-IN-14 reduces ear edema and inflammation in an atopic dermatitis mouse model[1].
Product Specifications
CAS Number
[3019972-01-8]
UNSPSC
12352005
Target
NF-κB; Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Immunology/Inflammation; NF-κB
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/nf-κb-in-14.html
Solubility
10 mM in DMSO
Smiles
CC1=CC=C(/C=C/CN2C=NC3=C(Cl)N=C(Cl)N=C23)C=C1
Molecular Formula
C15H12Cl2N4
Molecular Weight
319.19
References & Citations
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-162004/NF-κB-IN-14-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-162004/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
NF-κB; TLR4
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items